Celiac Plexus Block with Cancer Drugs for Pain Relief
A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
Recruiting
Observational Study
Advanced Biliary Tract Cancer(BTC)
Advanced Pancreatic Cancers
Cancer-related Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 103 (estimated)
- Sponsor
- Tongji Hospital · Other
Who this trial is looking for
This trial is looking for patients with advanced bile duct or pancreatic cancer who have been in pain. Taking part involves receiving a pain management procedure and starting standard cancer treatment while being monitored for up to 2 years.
Are You a Good Fit for This Trial?
You may be able to join if
- I have advanced bile duct or pancreatic cancer.
- I have been experiencing cancer-related pain.
- My pain score is 4 or higher for over a week.
- I am scheduled to receive first-line cancer treatment.
- My performance status is 0-2.
- I have an estimated life expectancy of at least 3 months.
You may not be able to join if
- I have had celiac plexus neurolysis before.
- I have a bleeding disorder.
- I have severe heart, liver, or kidney problems.
- I have a local infection or an anatomical issue that prevents the procedure.
- I have another condition that could make it unsafe for me to participate.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is for patients with advanced bile duct or pancreatic cancer who are experiencing pain from their disease. The purpose of this research is to learn about the effects of combining a standard pain relief treatment (Celiac Plexus Block) with standard first-line cancer drugs.
Patients in this study will receive the Celiac Plexus Block procedure, which is intended to reduce pain, and will t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histologically confirmed advanced biliopancreatic malignancy (including biliary tract cancer or pancreatic cancer).
* Cancer-related pain: Baseline Numeric Rating Scale (NRS) pain score ≥ 4 points for over 1 week, with plans to receive celiac plexus neurolysis (CPN).
* Schedul…
Contacts